66 related articles for article (PubMed ID: 21887474)
21. Expression of dynein, cytoplasmic 2, heavy chain 1 (DHC2) associated with glioblastoma cell resistance to temozolomide.
Wang H; Feng W; Lu Y; Li H; Xiang W; Chen Z; He M; Zhao L; Sun X; Lei B; Qi S; Liu Y
Sci Rep; 2016 Jul; 6():28948. PubMed ID: 27375225
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis.
Wu P; Wu D; Zhao L; Huang L; Shen G; Huang J; Chai Y
Oncotarget; 2016 Apr; 7(15):19863-83. PubMed ID: 26959884
[TBL] [Abstract][Full Text] [Related]
23. Low c-Met expression levels are prognostic for and predict the benefits of temozolomide chemotherapy in malignant gliomas.
Li MY; Yang P; Liu YW; Zhang CB; Wang KY; Wang YY; Yao K; Zhang W; Qiu XG; Li WB; Peng XX; Wang YZ; Jiang T
Sci Rep; 2016 Feb; 6():21141. PubMed ID: 26879272
[TBL] [Abstract][Full Text] [Related]
24. Activation of sonic hedgehog signaling enhances cell migration and invasion by induction of matrix metalloproteinase-2 and -9 via the phosphoinositide-3 kinase/AKT signaling pathway in glioblastoma.
Chang L; Zhao D; Liu HB; Wang QS; Zhang P; Li CL; Du WZ; Wang HJ; Liu X; Zhang ZR; Jiang CL
Mol Med Rep; 2015 Nov; 12(5):6702-10. PubMed ID: 26299938
[TBL] [Abstract][Full Text] [Related]
25. RAB34 was a progression- and prognosis-associated biomarker in gliomas.
Wang HJ; Gao Y; Chen L; Li YL; Jiang CL
Tumour Biol; 2015 Mar; 36(3):1573-8. PubMed ID: 25501506
[TBL] [Abstract][Full Text] [Related]
26. Association of pSTAT3-VEGF signaling pathway with peritumoral edema in newly diagnosed glioblastoma: an immunohistochemical study.
Wang XF; Lin GS; Lin ZX; Chen YP; Chen Y; Zhang JD; Tan WL
Int J Clin Exp Pathol; 2014; 7(9):6133-40. PubMed ID: 25337261
[TBL] [Abstract][Full Text] [Related]
27. STAT3 Tyr705 phosphorylation affects clinical outcome in patients with newly diagnosed supratentorial glioblastoma.
Lin GS; Yang LJ; Wang XF; Chen YP; Tang WL; Chen L; Lin ZX
Med Oncol; 2014 Apr; 31(4):924. PubMed ID: 24652192
[TBL] [Abstract][Full Text] [Related]
28. Rab27a was identified as a prognostic biomaker by mRNA profiling, correlated with malignant progression and subtype preference in gliomas.
Wang H; Zhao Y; Zhang C; Li M; Jiang C; Li Y
PLoS One; 2014; 9(2):e89782. PubMed ID: 24587032
[TBL] [Abstract][Full Text] [Related]
29. The effect of STAT3 inhibition on status epilepticus and subsequent spontaneous seizures in the pilocarpine model of acquired epilepsy.
Grabenstatter HL; Del Angel YC; Carlsen J; Wempe MF; White AM; Cogswell M; Russek SJ; Brooks-Kayal AR
Neurobiol Dis; 2014 Feb; 62():73-85. PubMed ID: 24051278
[TBL] [Abstract][Full Text] [Related]
30. Bortezomib overcomes MGMT-related resistance of glioblastoma cell lines to temozolomide in a schedule-dependent manner.
Vlachostergios PJ; Hatzidaki E; Befani CD; Liakos P; Papandreou CN
Invest New Drugs; 2013 Oct; 31(5):1169-81. PubMed ID: 23645448
[TBL] [Abstract][Full Text] [Related]
31. Propolis changes the anticancer activity of temozolomide in U87MG human glioblastoma cell line.
Markiewicz-Żukowska R; Borawska MH; Fiedorowicz A; Naliwajko SK; Sawicka D; Car H
BMC Complement Altern Med; 2013 Feb; 13():50. PubMed ID: 23445763
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
Sun S; Lee D; Ho AS; Pu JK; Zhang XQ; Lee NP; Day PJ; Lui WM; Fung CF; Leung GK
Neuro Oncol; 2013 May; 15(5):562-77. PubMed ID: 23444257
[TBL] [Abstract][Full Text] [Related]
33. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma.
Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS
Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773
[TBL] [Abstract][Full Text] [Related]
34. Aspirin-/TMZ-coloaded microspheres exert synergistic antiglioma efficacy via inhibition of β-catenin transactivation.
Shi ZD; Qian XM; Liu CY; Han L; Zhang KL; Chen LY; Zhang JX; Pu PY; Yuan XB; Kang CS;
CNS Neurosci Ther; 2013 Feb; 19(2):98-108. PubMed ID: 23230963
[TBL] [Abstract][Full Text] [Related]
35. EGFR and c-Met Cross Talk in Glioblastoma and Its Regulation by Human Cord Blood Stem Cells.
Velpula KK; Dasari VR; Asuthkar S; Gorantla B; Tsung AJ
Transl Oncol; 2012 Oct; 5(5):379-92. PubMed ID: 23066446
[TBL] [Abstract][Full Text] [Related]
36. Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.
Sen M; Joyce S; Panahandeh M; Li C; Thomas SM; Maxwell J; Wang L; Gooding WE; Johnson DE; Grandis JR
Clin Cancer Res; 2012 Sep; 18(18):4986-96. PubMed ID: 22825581
[TBL] [Abstract][Full Text] [Related]
37. Wnt/beta-catenin signaling in glioma.
Zhang K; Zhang J; Han L; Pu P; Kang C
J Neuroimmune Pharmacol; 2012 Dec; 7(4):740-9. PubMed ID: 22454041
[TBL] [Abstract][Full Text] [Related]
38. Nuclear translocation of β-catenin is essential for glioma cell survival.
Shi Z; Qian X; Li L; Zhang J; Zhu S; Zhu J; Chen L; Zhang K; Han L; Yu S; Pu P; Jiang T; Kang C
J Neuroimmune Pharmacol; 2012 Dec; 7(4):892-903. PubMed ID: 22415719
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of STAT3 reverses alkylator resistance through modulation of the AKT and β-catenin signaling pathways.
Wang Y; Chen L; Bao Z; Li S; You G; Yan W; Shi Z; Liu Y; Yang P; Zhang W; Han L; Kang C; Jiang T
Oncol Rep; 2011 Nov; 26(5):1173-80. PubMed ID: 21887474
[TBL] [Abstract][Full Text] [Related]
40. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
